Moreover, as activation of the CXCL12/CXCR4 axis stimulates VEGF and MMP production in mature endothelial cells (138), CXCR4 antagonists also inhibit tumor angiogenesis in animal models of human tumors (68). The gene discussed is CXCL12; the disease is neoplasm.